Trial Profile
An 16-Week, Randomized, Open label, Haloperidol-Controlled Study to Evaluate the Efficacy of Paliperidone In Improving Social Cognitive Function of Patients with Schizophrenia
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2016
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary) ; Haloperidol
- Indications Schizophrenia
- Focus Therapeutic Use
- 26 Apr 2016 New trial record